You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CC-90007

Showing 1 - 25 of 800
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatic Impairment Trial in Miami, Orlando, Knoxville (Enasidenib)

Recruiting
  • Hepatic Impairment
  • Miami, Florida
  • +4 more
Nov 27, 2022

Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)

Recruiting
  • Acute Myeloid Leukemia
  • Decitabine and Cedazuridine
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Acute Myeloid Leukemia Trial in Columbus (Azacitidine, Biopsy, Enasidenib)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jun 30, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Decitabine and

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine and Cedazuridine
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Recurrent Acute Myeloid Leukemia Trial in United States (Enasidenib Mesylate, Liposome-encapsulated Daunorubicin-Cytarabine)

Suspended
  • Recurrent Acute Myeloid Leukemia
  • Enasidenib Mesylate
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • Los Angeles, California
  • +3 more
Sep 27, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Cobimetinib, Enasidenib Mesylate)

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Duarte, California
    City of Hope Medical Center
Jun 28, 2022

Acute Myeloid Leukemia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in Baltimore,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Baltimore, Maryland
  • +2 more
Feb 25, 2022

Hepatic Impairment Trial in United States (Enasidenib)

Completed
  • Hepatic Impairment
  • Lakewood, Colorado
  • +4 more
Jul 16, 2020

Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Bosutinib Monohydrate
  • +6 more
  • Duarte, California
    City of Hope Meidcal Center
Jun 7, 2022

Pharmacogenetics Sampling of the CC-90007-CP-003 Study Cohort

Completed
  • Hepatic Insufficiency
    • Miami, Florida
    • +2 more
    May 20, 2020

    Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Canada, United States (Enasidenib, Enasidenib

    Recruiting
    • Recurrent Acute Myeloid Leukemia
    • Refractory Acute Myeloid Leukemia
    • Birmingham, Alabama
    • +17 more
    Jun 21, 2021

    Blasts Under 5 Percent of Peripheral Blood White Cells, Bone Marrow Blasts Decreased by 50 Percent or More Compared to

    Withdrawn
    • Blasts Under 5 Percent of Peripheral Blood White Cells
    • +4 more
    • Buffalo, New York
    • +1 more
    Mar 8, 2021

    Healthy Volunteers Trial in Austin (Enasidenib)

    Completed
    • Healthy Volunteers
    • Austin, Texas
      PPD Development, LP
    Mar 13, 2020

    Leukemia, Myeloid, Isocitrate Dehydrogenase Trial in Worldwide (AG-221, BSC, Azacitidine)

    Active, not recruiting
    • Leukemia, Myeloid
    • Isocitrate Dehydrogenase
    • Los Angeles, California
    • +145 more
    Jun 7, 2022

    Acute Myeloid Leukemia Trial in Summit (AG-221)

    No longer available
    • Acute Myeloid Leukemia
    • Summit, New Jersey
      Celgene
    Oct 23, 2019

    Solid Tumor, Adult Trial in Korea, Republic of, United States (TTX-030, budigalimab and mFOLFOX6, TTX-030, budigalimab and

    Active, not recruiting
    • Solid Tumor, Adult
    • TTX-030, budigalimab and mFOLFOX6
    • +7 more
    • Scottsdale, Arizona
    • +31 more
    Oct 18, 2022

    Non-Hodgkin Lymphoma Trial (CC-122, Dexamethasone)

    Not yet recruiting
    • Non-Hodgkin Lymphoma
    • (no location specified)
    Jan 10, 2023

    Acromioclavicular Joint Dislocation Trial in Chon Buri (K-wire)

    Recruiting
    • Acromioclavicular Joint Dislocation
    • K-wire
    • Chon Buri, Thailand
      Queen Savang Vadhana Memorial Hospital
    May 2, 2023

    Multiple Myeloma Trial in Worldwide (CC-220, Dexamethasone, Daratumumab)

    Recruiting
    • Multiple Myeloma
    • Scottsdale, Arizona
    • +126 more
    Jan 10, 2023

    Cervical Cancer Trial (Game Changers for Cervical Cancer Prevention)

    Not yet recruiting
    • Cervical Cancer
    • Game Changers for Cervical Cancer Prevention
    • (no location specified)
    Aug 17, 2023

    Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)

    Active, not recruiting
    • Lymphoma, Large B-Cell, Diffuse
    • Santa Barbara, California
    • +22 more
    Jan 25, 2023

    Colorectal Cancer Trial (Administration of CC-3)

    Not yet recruiting
    • Colorectal Cancer
    • Administration of CC-3
    • (no location specified)
    Aug 11, 2023

    Eosinophilic Esophagitis Trial in Worldwide (CC-93538, Placebo)

    Recruiting
    • Eosinophilic Esophagitis
    • Birmingham, Alabama
    • +417 more
    Jan 23, 2023

    Advanced Solid Tumors Trial in Madrid ([14C]CC-90010, CC-90010)

    Not yet recruiting
    • Advanced Solid Tumors
    • Madrid, M, Spain
    • +1 more
    Dec 23, 2022

    Leukemia, Myeloid, Acute Trial in Worldwide (CC-90009, Venetoclax, Azacitidine)

    Recruiting
    • Leukemia, Myeloid, Acute
    • San Francisco, California
    • +25 more
    Jan 9, 2023